RecruitingPhase 2NCT06483659

Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy

Sponsor

Brigham and Women's Hospital

Enrollment

152 participants

Start Date

Jun 1, 2025

Study Type

INTERVENTIONAL

Conditions

Postoperative Pain

Summary

This is a randomized, double-blinded, placebo-controlled trial to compare the effectiveness of IV oxytocin infusion to placebo on peri-operative opioid consumption and reducing post-operative pain following a minimally invasive hysterectomy under general anesthesia.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Oxytocin and a drug called Placebo for people with postoperative pain. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.